Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Prostate Cancer Treatment Seen Drawing Medivation Bids: Real M&A
Bloomberg
Monday, July 16, 2012 - 8:48am
tags:
prostate cancer, Medivation, M&A, AbbVie, Astellas, Enzalutamide
Sanofi: Don't Ignore This Powerhouse
Seeking Alpha
Monday, July 16, 2012 - 8:47am
tags:
Sanofi, Merck, Pfizer, Bristol-Myers Squibb, Bayer
Partnership and Acquisition in the Red Hot Weight Loss Market
Motley Fool
Monday, July 16, 2012 - 8:45am
tags:
Vivus, Arena Pharmaceuticals, obesity, M&A, Qnexa, Belviq, Pfizer, JNJ, Eisai
Spectrum Pharmaceuticals: Bears Beware, Fusilev Strength Points To Strong Second Quarter
Seeking Alpha
Sunday, July 15, 2012 - 12:25pm
tags:
Fusilev, Spectrum Pharmaceuticals, colorectal cancer, colon cancer
Kala Pharmaceuticals Co-founder Publishes Data on Novel Therapeutic Approach to Overcome Mucosal Barrier for Prevention of Herpes Simplex Virus-2 Infection
PharmaLive
Sunday, July 15, 2012 - 12:18pm
tags:
Kala Pharmaceuticals, herpes, herpes simplex 2
Alnylam Inks Oncology Deal - Analyst Blog
NASDAQ
Sunday, July 15, 2012 - 12:11pm
tags:
Alnylam, Ascletis Pharmaceuticals, ALN-VSP
Bayer HealthCare to Present Data on Secondary Prophylaxis with Kogenate(R) FS -- antihemophilic factor (recombinant) on Bleeding Frequency in Adults and Adolescents with Severe Hemophilia A
PharmaLive
Sunday, July 15, 2012 - 12:10pm
tags:
Kogenate, Bayer, antihemophilic factor, hemophilia
Profit From GlaxoSmithKline's Mistake
Seeking Alpha
Sunday, July 15, 2012 - 12:06pm
tags:
GSK
Watson will market generic morning after pill
San Francisco Chronicle, CA
Sunday, July 15, 2012 - 12:05pm
tags:
Watson Pharmaceuticals, Plan B contraceptive, Teva Pharmaceuticals, generics
Piper Jaffray Boosts Target on BioMarin to $52 After Addition of BMN-701 to Model
Street Insider
Sunday, July 15, 2012 - 12:02pm
tags:
BMN-701, Biomarin, Pompe disease
Ampio announces exercise of over-allotment option
Yahoo/The Fly On The Wall
Sunday, July 15, 2012 - 11:54am
tags:
Ampio Pharmaceuticals
EU agency lifts lid on drug data secrets
Reuters
Sunday, July 15, 2012 - 11:51am
tags:
Clinical Data, drug data
Bristol-Myers Squibb: Don't Miss This Attractive Entry Point
Seeking Alpha
Sunday, July 15, 2012 - 11:49am
tags:
Bristol-Myers Squibb
Celgene's Treading Into Open Water
Motley Fool
Sunday, July 15, 2012 - 11:41am
tags:
Celgene
Can Eli Lilly Save This Drug?
Motley Fool
Sunday, July 15, 2012 - 11:40am
tags:
Eli Lilly, pomaglumetad methionil, schizophrenia
2 Pharma Companies Investors Should Avoid At Current Levels
Seeking Alpha
Sunday, July 15, 2012 - 11:39am
tags:
Ampio Pharmaceuticals, Dendreon
GSK in weekend talks to buy Human Genome: sources
Reuters
Sunday, July 15, 2012 - 11:37am
tags:
GSK, Human Genome Sciences, M&A
China Biotech In Review: Deals, Trials And Regulations
Seeking Alpha
Sunday, July 15, 2012 - 11:36am
tags:
Ascletis, Walvax Biotech, Fengmao Biotech, Siegfried Holding, Oculus Innovative Sciences
Hedge Funds Are Buying These 10 High-Growth Biotech Stocks
Seeking Alpha
Sunday, July 15, 2012 - 11:30am
tags:
Xoma, Jazz Pharmaceuticals, Pacific Biosciences, Amylin, Corcept Therapeutics, Santarus, Affymetrix, Ariad Pharmaceuticals, Amyris, Sequenom
3 Reasons to Buy Spectrum Pharmaceuticals
Motley Fool
Sunday, July 15, 2012 - 11:28am
tags:
Spectrum Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.